Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00682981 · ClinicalTrials.gov registry record · Phase 1
A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)
A Phase 1 study, sponsored by Gemin X.
- Completed
- Registry status
- Phase 1
- Development phase
- 218
- Enrollment target
NCT00682981: Completed Phase 1 study, sponsored by Gemin X.
NCT00682981 is a Phase 1 study that has completed, run by Gemin X. The registered enrollment target is 218 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (263% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00682981, a Phase 1 study, has completed, sponsored by Gemin X.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 218 participants
- Enrollment target
Study Summary
The Phase I portion of this protocol will determine the best phase II dose and schedule of obatoclax with carboplatin and etoposide in patients with extensive-stage small cell lung cancer. The Phase II portion will evaluate the response rate to this regimen.
Interventions
- DRUG Obatoclax
- DRUG Carboplatin/etoposide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2008-05 |
| Est. Completion | 2011-11 |
| Phase | Phase 1 |
What the finished NCT00682981 record still lists
NCT00682981 is an interventional study that assigns participants to a tested intervention. The registered 218 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (263% higher).
The record links to 0 conditions, and to 2 interventions - of which Obatoclax is the first listed.
NCT00682981 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00682981 about?
NCT00682981 is a clinical study titled "A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)". The Phase I portion of this protocol will determine the best phase II dose and schedule of obatoclax with carboplatin and etoposide in patients with extensive-stage small cell lung cancer. The Phase II portion will evaluate the response rate to this regimen.
What is the current status of trial NCT00682981?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 218 participants. The study started on 2008-05. Estimated completion is 2011-11.
What interventions are being tested in trial NCT00682981?
The interventions under investigation include: Obatoclax (DRUG), Carboplatin/etoposide (DRUG).
Who is sponsoring clinical trial NCT00682981?
This trial is sponsored by Gemin X, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00682981's enrollment target sits among peer trials
218 239th of 2000 higher than 1,761 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04693858 · 218 participants · NA
Efficacy Trial of the CALM Intervention
- NCT05909202 · 218 participants · NA
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
- NCT06000761 · 218 participants · NA
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
- NCT06249126 · 218 participants · NA
Primary Subtalar Arthrodesis for Calcaneal Fractures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia